available for iOS, Android & web
June 24, 2011
The US Supreme Court has ruled that the duty of brand-name drugmakers to warn patients about side effects or complications with their products does not extend to the manufacturers of generic copies.
Making patients smile
Patients’ wellbeing can be just as important as
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions